Response to "complexity of interstitial lung disease disproportionality signal analysis in pharmacovigilance databases".
作者信息
Zhu Zijun, Li Yongxin, Zhao Jiuda
机构信息
Breast Disease Diagnosis and Treatment Center, Affiliated Hospital of Qinghai University, Affiliated Cancer Hospital of Qinghai University, Xining, China.
出版信息
EClinicalMedicine. 2025 Aug 20;87:103451. doi: 10.1016/j.eclinm.2025.103451. eCollection 2025 Sep.
Abstract
摘要
相似文献
1
Response to "complexity of interstitial lung disease disproportionality signal analysis in pharmacovigilance databases".
EClinicalMedicine. 2025 Aug 20;87:103451. doi: 10.1016/j.eclinm.2025.103451. eCollection 2025 Sep.
2
Complexity of interstitial lung disease disproportionality signal analysis in pharmacovigilance databases.
EClinicalMedicine. 2025 Aug 21;87:103450. doi: 10.1016/j.eclinm.2025.103450. eCollection 2025 Sep.
3
Interstitial lung disease induced by fluoxetine: Systematic review of literature and analysis of Vigiaccess, Eudravigilance and a national pharmacovigilance database.
Pharmacol Res. 2017 Jun;120:294-301. doi: 10.1016/j.phrs.2017.04.010. Epub 2017 Apr 12.
4
The Role of Disproportionality Analysis of Pharmacovigilance Databases in Safety Regulatory Actions: a Systematic Review.
Curr Drug Saf. 2015;10(3):234-50. doi: 10.2174/1574886310666150729112903.
5
Safety profile of belatacept in a real-life setting: disproportionality analysis of the WHO pharmacovigilance database.
BMC Pharmacol Toxicol. 2025 Aug 11;26(1):147. doi: 10.1186/s40360-025-00972-6.
6
Disproportionality analysis on semaglutide and nonarteritic anterior ischemic optic neuropathy in the FDA adverse event reporting system: An emerging pharmacovigilance signal?
Obes Res Clin Pract. 2025 Mar-Apr;19(2):178-180. doi: 10.1016/j.orcp.2025.03.001. Epub 2025 Mar 24.
7
Global burden of insomnia medication-associated suicidality, 1967-2024: A disproportionality analysis of the global pharmacovigilance database.
Psychiatry Res. 2025 Sep;351:116587. doi: 10.1016/j.psychres.2025.116587. Epub 2025 Jun 8.
8
Identification of the Top 15 Drugs Associated With Anaphylaxis: A Pharmacovigilance Study.
Clin Exp Allergy. 2025 Jul;55(7):541-551. doi: 10.1111/cea.70092. Epub 2025 Jun 8.
9
Adverse events associated with mesalazine in the real-world: A comprehensive pharmacovigilance analysis of the FAERS and JADER databases.
Pharmazie. 2025 Aug 1;80(4):60-69. doi: 10.1691/ph.2025.5549.
10
Gender and age disparities in cardiac immune-related adverse events associated with immune checkpoint inhibitors: a pharmacovigilance analysis of the FAERS database.
BMJ Open. 2025 Jun 12;15(6):e090087. doi: 10.1136/bmjopen-2024-090087.
本文引用的文献
1
The REporting of A Disproportionality Analysis for DrUg Safety Signal Detection Using Individual Case Safety Reports in PharmacoVigilance (READUS-PV): Explanation and Elaboration.
Drug Saf. 2024 Jun;47(6):585-599. doi: 10.1007/s40264-024-01423-7. Epub 2024 May 7.
2
Cardiovascular toxicity induced by SSRIs: Analysis of spontaneous reports submitted to FAERS.
Psychiatry Res. 2023 Aug;326:115300. doi: 10.1016/j.psychres.2023.115300. Epub 2023 Jun 22.
3
Cardiovascular and pulmonary adverse events in patients treated with BCR-ABL inhibitors: Data from the FDA Adverse Event Reporting System.
Am J Hematol. 2015 Apr;90(4):E66-72. doi: 10.1002/ajh.23938. Epub 2015 Jan 30.
4
Quantitative signal detection using spontaneous ADR reporting.
Pharmacoepidemiol Drug Saf. 2009 Jun;18(6):427-36. doi: 10.1002/pds.1742.
Zotero 插件